| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Finance &Administration | EVP, Chief Financial Officer
3 companies
Chase William J is an EVP, Finance &Administration at AbbVie Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 5 sells.
Estimated insider holdings value: $38.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | NTLA Intellia Therapeutics, Inc. | Director | Buy | 100,000 | $10.03 | $1,003,000.00 | +288.2% | -17.0% | - | |
| Jun 26, 2019 | ABBV Abbvie Inc. | EVP, Finance &Administration | Buy | 30,400 | $67.30 | $2,045,920.00 | +21.8% | - | - | |
| Dec 12, 2018 | ABBV Abbvie Inc. | EVP, Finance &Administration | Sell | 60,000 | $90.00 | $5,400,000.00 | -36.4% | - | - | |
| Mar 1, 2018 | ABBV Abbvie Inc. | EVP, Chief Financial Officer | Sale+OE | 70,928 | $117.18 | $8,311,640.44 | -17.7% | - | - | |
| May 18, 2017 | ABBV Abbvie Inc. | EVP, Chief Financial Officer | Sale+OE | 38,300 | $65.35 | $2,502,905.00 | -17.3% | - | - | |
| Dec 2, 2016 | ABBV Abbvie Inc. | EVP, Chief Financial Officer | Sale+OE | 6,600 | $59.19 | $390,654.00 | -3.7% | - | - |